Filing Details
- Accession Number:
- 0001601485-22-000045
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-05-27 16:20:09
- Reporting Period:
- 2021-02-09
- Accepted Time:
- 2022-05-27 16:20:09
- Original Submission Date:
- 2021-02-11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1601485 | Angion Biomedica Corp. | ANGN | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1413350 | Jay Venkatesan | C/O Angion Biomedica Corp. 51 Charles Lindbergh Blvd. Uniondale NY 11553 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-09 | 396,329 | $6.43 | 1,598,440 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2021-02-09 | 159,177 | $16.00 | 1,367,263 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-02-09 | 262 | $11.57 | 1,439,525 | No | 4 | C | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | S | Direct | |
| No | 4 | C | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant to Purchase Common Stock | Disposition | 2021-02-09 | 396,329 | $0.00 | 396,329 | $6.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-07-05 | No | 4 | X | Direct |
Footnotes
- On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 396,329 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 159,177 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 237,152 shares of common stock.
Billionaire Hedge Funds
